BMY Bristol-Myers Squibb Co.

47.79-0.42 (-0.87%)
Close: June 18, 2019

47.900.11 (+0.23%)
Pre-market

Quote

Previous Close
$47.79
Day Range
$47.71-$48.68
52 Week Range
$44.30-$63.69
Volume
11,516,107
Avg Volume
11,721,736
Dividend TTM
$1.62 (3.36%)
Ex-Dividend Date
2019-07-03

Valuation

Market Cap
$78.17B
Enterprise Value (EV)
$76.26B
PE Ratio
15.09
EV/EBITDA
10.75
Price/Sales
3.45
Price/Book
5.57
PEG Ratio
0.89

Financials

Revenue
$22.56B
Gross Profit
$16.08B
EBITDA
$7.10B
EPS, ttm
$3.17
Profit Margin
21.81%
Revenue/Employee
$968.28K
Next Earnings Date
7/25/2019 (36 days)
Debt to Equity
52%
Debt
$6.97B
Cash
$8.88B
Net Debt
-

Performance

Beta
0.93
200 Day Moving Avg
$51.41
50 Day Moving Avg
$46.51
52 Week Change
-10.14%
YTD Change
-8.92%
1 Month Change
4.10%
3 Month Change
-3.31%
6 Month Change
-6.50%
1 Year Change
-10.14%
2 Year Change
-12.45%
5 Year Change
-5.26%

Share Count

Shares Outstanding
1.6B
Float
1.6B
Restricted Shares
5.4M
Restricted Shares, %
0.33%

Bristol-Myers Squibb Co. Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Giovanni Caforio

Website: http://www.bms.com

Description: Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Employees: 23,300